z-logo
open-access-imgOpen Access
A two-site, open-label, non-randomized trial comparing Focal Electrically-Administered Seizure Therapy (FEAST) and right unilateral ultrabrief pulse electroconvulsive therapy (RUL-UBP ECT)
Author(s) -
Gregory L. Sahlem,
W. Vaughn McCall,
E. Baron Short,
Peter B. Rosenquist,
James Fox,
Nagy A. Youssef,
Andrew Manett,
Suzanne E. U. Kerns,
Morgan Dancy,
Laryssa McCloud,
Mark S. George,
Harold A. Sackeïm
Publication year - 2020
Publication title -
brain stimulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.685
H-Index - 81
eISSN - 1935-861X
pISSN - 1876-4754
DOI - 10.1016/j.brs.2020.07.015
Subject(s) - electroconvulsive therapy , open label , anesthesia , pulse (music) , medicine , seizure threshold , randomized controlled trial , electroconvulsive shock , surgery , epilepsy , psychiatry , anticonvulsant , physics , detector , optics
Focal Electrically-Administered Seizure Therapy (FEAST) is a form of electroconvulsive therapy (ECT) that spatially focuses the electrical stimulus to initiate seizure activity in right prefrontal cortex. Two open-label non-comparative studies suggested that FEAST has reduced cognitive side effects when compared to historical data from other forms of ECT. In two different ECT clinics, we compared the efficacy and cognitive side effects of FEAST and Right Unilateral Ultrabrief Pulse (RUL-UBP) ECT.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom